Laetrile/Amygdalin (PDQ®)–Patient Version
Laetrile (Amygdalin) has shown little anticancer activity in animal studies and no anticancer activity in human clinical trials. Laetrile is not approved for use in the United States. Learn more about the use of Laetrile for cancer in this expert-reviewed summary.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/6073/syndication
- Syndication ID: 1639
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Saturday, September 14, 2013 at 09:03 AM
- Date Syndication Updated: Monday, August 05, 2019 at 07:42 PM
Tags
General:
patient
version
laetrileamygdalin
laetrile
Embed Code Snippet
To get the embed code snippet please Login.